Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases
Cancers · 13.04.2023 · 15 (8) · 2272
DOI: 10.3390/cancers15082272 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 13.04.2023. Verfasst von Sunil Kumar Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Chicago, IL 60612, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, BLRD VA, Veterans Affairs Merit Award.
Abstract (Originalsprache)
Mitogen-activated protein kinase (MAPK) cascades are crucial in extracellular signal transduction to cellular responses. The classical three-tiered MAPK cascades include signaling through MAP kinase kinase kinase (MAP3K) that activates a MAP kinase kinase (MAP2K), which in turn induces MAPK activation and downstream cellular responses. The upstream activators of MAP3K are often small guanosine-5′-triphosphate (GTP)-binding proteins, but in some pathways, MAP3K can be activated by another kinase, which is known as a MAP kinase kinase kinase kinase (MAP4K). MAP4K4 is one of the widely studied MAP4K members, known to play a significant role in inflammatory, cardiovascular, and malignant diseases. The MAP4K4 signal transduction plays an essential role in cell proliferation, transformation, invasiveness, adhesiveness, inflammation, stress responses, and cell migration. Overexpression of MAP4K4 is frequently reported in many cancers, including glioblastoma, colon, prostate, and pancreatic cancers. Besides its mainstay pro-survival role in various malignancies, MAP4K4 has been implicated in cancer-associated cachexia. In the present review, we discuss the functional role of MAP4K4 in malignant/non-malignant diseases and cancer-associated cachexia and its possible use in targeted therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Chicago, IL 60612, USA.
- UICentre for Drug Discovery, University of Illinois at Chicago, Chicago, IL 60612, USA.
- University of Illinois Hospital & Health Sciences System Cancer Center, University of Illinois at Chicago, Chicago, IL 60612, USA.
- Jesse Brown VA Medical Center, Chicago, IL 60612, USA.
ORCID-Profile: Sunil Kumar Singh, Piush Srivastava
Förderung
- NCI NIH HHS
- BLRD VA
- Veterans Affairs Merit Award
- Career Scientist Award
- VA-Merit award
- United States Department of Veterans Affairs grant
- National Cancer Institute
- UIC-Cancer Center pilot grant award
Zitieren
APA
Singh, S. K., Roy, R., Kumar, S., Srivastava, P., Jha, S., Rana, B., & Rana, A. (2023). Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases. Cancers, 15(8), 2272. https://doi.org/10.3390/cancers15082272
Vancouver
Singh SK, Roy R, Kumar S, Srivastava P, Jha S, Rana B, et al. Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases. Cancers. 2023;15(8):2272. doi:10.3390/cancers15082272
BibTeX
@article{Singh2023,
author = {Singh, Sunil Kumar and Roy, Ruchi and Kumar, Sandeep and Srivastava, Piush and Jha, Saket and Rana, Basabi and Rana, Ajay},
title = {Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases},
journal = {Cancers},
year = {2023},
volume = {15},
number = {8},
pages = {2272},
doi = {10.3390/cancers15082272}
}
EUVIMED